Cartilage Repair And Regeneration Market: By Types of Cartilage (Fibrocartilage, Hyaline Cartilage, Elastic Cartilage, Others), By Treatment Modality (Cell-based, Non-Cell-based) By Treatment Type (Palliative, Intrinsic Repair Stimulus), By Application (Knee, Spine, Ankle, Hip, Others), By Surgical Procedure (Chondroplasty and Microfracture, Autologous Chondrocyte Implantation, Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation, Juvenile Allograft Fragments, Others), By End User (Ambulatory Care Centres, Hospitals and Clinics, Surgical Centres, and Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Cartilage Repair And Regeneration Market Size was valued at USD 1,523.7 million in 2022 and is poised to grow at a CAGR of 12.8% over 2023-2029. The cartilage repair and regeneration market refers to the area of the medical industry that focuses on creating and offering remedies for the regeneration of damaged or degenerated cartilage in the human body, which is vital for supporting structural integrity and enabling pain-free joint movement. The increased prevalence of joint disorders such as osteoarthritis and rheumatoid arthritis drives the demand for effective cartilage repair and regeneration solutions market. According to WHO, in 2019, about 528 million people worldwide were living with osteoarthritis; 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Furthermore, the rise in the number of people suffering from sports-related injuries like athletes and active individuals, particularly those involving joints like the knees and shoulders is anticipated to propel the market in the upcoming years. According to a study conducted by Johns Hopkins Hospital, in the U.S. about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year with one-third of all injuries incurred in children.

Additionally, the development of non-invasive and regenerative techniques like ultrasound-guided therapies has provided several opportunities for the expansion of the market. Currently, 3D printing technology to aid in more efficient tissue regeneration and develop patient-specific scaffolds and structures that resemble the environment found in native cartilage is trending in the market. For instance, in 2021, Scientists from the Nakayama Lab at Saga University and Kyoto University in Japan have fabricated 3D-printed cartilage constructs from stem cells which could potentially be used to repair large cartilage defects in patients. But the regulatory hurdles for the approval of a particular product or therapy can be complex, time-consuming and expensive and may hinder the market growth. However, the increased incidence of osteoarthritis, increased funding and investments for research and launch of new products by key companies, increased government health initiatives, advanced infrastructure and instrumentation are anticipated to burgeon the market growth during the forecast years.

Cartilage Repair And Regeneration Market Key Developments:
  • In April 2022, Bioventus acquired fellow orthopaedic device-maker CartiHeal for a deal worth up to $450 Million.
  • In July 2021, The HYALEX Cartilage System, of Hyalex Orthopaedics was granted breakthrough device designation for its ability to restore function in patients who lost knee articular cartilage and bone and need a surgical procedure.
  • In 2019, Smith & Nephew acquired Osiris Therapeutics, Inc. (US). This acquisition increased the company’s customer base and enhanced the advanced wound care management segment of Smith & Nephew.

Global Cartilage Repair Regeneration Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Cartilage Repair And Regeneration Market Dynamics

The market is expected to rise as the number of knee replacement surgeries performed has increased and it dominates the market. The increase in the number of geriatric populations is anticipated to drive the market owing to the increase in damaged, worn, diseased knees or arthritis. According to the CDC, in the U.S., among adults aged 65 and older, 50% report ever having been diagnosed with arthritis. Similarly, according to NHS, more than 70,000 knee replacements are carried out in England and Wales each year, and the number is rising. Additionally, expanded R&D, the introduction of new products, mergers, and acquisitions are all contributing to the market's expansion. For instance, Minor League Baseball and Stryker worked together in April 2021 to officially designate Stryker as SmartRobotics' joint replacement partner. Stryker's newest innovation in joint replacement technology, Mako SmartRobotics, replaces the hip and knee using 3D CT-based planning software.

Key Features of the Reports

  • The cartilage repair and regeneration market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Cartilage Repair Regeneration Market Segmentation

By Type
  • Fibrocartilage
  • Hyaline Cartilage
  • Elastic Cartilage
  • Others
By Treatment Modality
  • Cell-based
    • Chondrocyte Transplantation
    • Stem Cells
    • Growth Factors
  • Non-cell-based
    • Tissue Scaffolds
    • Cell-free Composites
By Treatment Type
  • Palliative
  • Intrinsic Repair Stimulus
By Application
  • Knee
  • Spine
  • Ankle
  • Hip
  • Others
By Surgical Procedure
  • Chondroplasty and Microfracture
  • Autologous Chondrocyte Implantation
  • Osteochondral Autograft Transplantation
  • Osteochondral Allograft Transplantation
  • Juvenile Allograft Fragment
  • Others
By End Users
  • Ambulatory Care Centres
  • Hospitals and Clinics
  • Surgical Centres
  • Others

Frequently Asked Questions

The cartilage repair and regeneration market size was valued at USD 1,523.7 million in 2022 and is expected to grow at 12.8% CAGR over the forecast period 2023 – 2029.

Osiris Therapeutics, Inc. (U.S.), Smith + Nephew (U.K.), AlloSource (U.S.), Vericel Corporation (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), Stryker (U.S.), Anika Therapeutics, Inc. (U.S.), B. Braun SE (Germany), Orthocell Ltd. (Australia), Geistlich Pharma AG (Switzerland), Takeda Pharmaceutical Company Limited (Japan), CONMED Corporation (U.S.), The Future of Biotechnology, MEDIPOST (South Korea), BioTissue (U.S.), LifeNet Health (U.S.), RTI Surgical (U.S.) and Arthrex, Inc. (Germany) are a few companies operating in Cartilage Repair Market / Cartilage Regeneration market.

North America dominates the market with 13.8% CAGR in 2022, and is anticipated to grow with 14.1% CAGR over the forecast period 2023-2029.

1.Executive Summary
2.Global Cartilage Repair  And Regeneration Market Introduction 
2.1.Global Cartilage Repair  And Regeneration Market  - Taxonomy
2.2.Global Cartilage Repair  And Regeneration Market  - Definitions
2.2.1. By Type 
2.2.2. By Treatment Modality
2.2.3. By Treatment Type
2.2.4. By Application
2.2.5. By Surgical Procedure
2.2.6. By End User
2.2.7. By Region
3.Global Cartilage Repair  And Regeneration Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cartilage Repair  And Regeneration Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cartilage Repair  And Regeneration Market  By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Fibrocartilage
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Hyaline Cartilage
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Elastic Cartilage
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Cartilage Repair  And Regeneration Market  By Treatment Modality, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Cell-based
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Non-cell-based
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Cartilage Repair  And Regeneration Market  By Treatment Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Palliative
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Intrinsic Repair Stimulus
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Cartilage Repair  And Regeneration Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Knee
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Spine
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Ankle
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Hip
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Others
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.Global Cartilage Repair  And Regeneration Market  By Surgical Procedure, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Chondroplasty and Microfracture
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Autologous Chondrocyte Implantation
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Osteochondral Autograft Transplantation
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Osteochondral Allograft Transplantation
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Juvenile Allograft Fragment
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
9.6. Others
9.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.6.3. Market Opportunity Analysis 
10.Global Cartilage Repair  And Regeneration Market  By End USer, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Ambulatory Care Centres
10.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
10.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.1.3. Market Opportunity Analysis 
10.2. Hospitals and Clinics
10.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
10.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.2.3. Market Opportunity Analysis 
10.3. Surgical Centres
10.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
10.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.3.3. Market Opportunity Analysis 
10.4. Others
10.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
10.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
10.4.3. Market Opportunity Analysis 
11.Global Cartilage Repair  And Regeneration Market  By Region, 2018 - 2022 and Forecast 2023 - 20211 (Sales Value USD Million)
11.1. North America
11.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million)
11.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
11.1.3. Market Opportunity Analysis 
11.2. Europe
11.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million)
11.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
11.2.3. Market Opportunity Analysis 
11.3. Asia Pacific (APAC)
11.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million)
11.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
11.3.3. Market Opportunity Analysis 
11.4. Middle East and Africa (MEA)
11.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million)
11.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
11.4.3. Market Opportunity Analysis 
11.5. Latin America
11.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 20211, (Sales Value USD Million)
11.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
11.5.3. Market Opportunity Analysis 
12.North America Cartilage Repair  And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Fibrocartilage
12.1.2.Hyaline Cartilage
12.1.3.Elastic Cartilage
12.1.4.Others
12.2.  Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cell-based
12.2.2.Non-cell-based
12.3.  Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Palliative
12.3.2.Intrinsic Repair Stimulus
12.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Knee
12.4.2.Spine
12.4.3.Ankle
12.4.4.Hip
12.4.5.Others
12.5.  Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.Chondroplasty and Microfracture
12.5.2.Autologous Chondrocyte Implantation
12.5.3.Osteochondral Autograft Transplantation
12.5.4.Osteochondral Allograft Transplantation
12.5.5.Juvenile Allograft Fragment
12.5.6.Others
12.6.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.6.1.Ambulatory Care Centres
12.6.2.Hospitals and Clinics
12.6.3.Surgical Centres
12.6.4.Others
12.7.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.7.1.United States of America (USA)
12.7.2.Canada
13.Europe Cartilage Repair  And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Fibrocartilage
13.1.2.Hyaline Cartilage
13.1.3.Elastic Cartilage
13.1.4.Others
13.2.  Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cell-based
13.2.2.Non-cell-based
13.3.  Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Palliative
13.3.2.Intrinsic Repair Stimulus
13.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Knee
13.4.2.Spine
13.4.3.Ankle
13.4.4.Hip
13.4.5.Others
13.5.  Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.Chondroplasty and Microfracture
13.5.2.Autologous Chondrocyte Implantation
13.5.3.Osteochondral Autograft Transplantation
13.5.4.Osteochondral Allograft Transplantation
13.5.5.Juvenile Allograft Fragment
13.5.6.Others
13.6.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.6.1.Ambulatory Care Centres
13.6.2.Hospitals and Clinics
13.6.3.Surgical Centres
13.6.4.Others
13.7.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.7.1.Germany
13.7.2.France
13.7.3.Italy
13.7.4.United Kingdom (UK)
13.7.5.Spain
14.Asia Pacific (APAC) Cartilage Repair  And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Fibrocartilage
14.1.2.Hyaline Cartilage
14.1.3.Elastic Cartilage
14.1.4.Others
14.2.  Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Cell-based
14.2.2.Non-cell-based
14.3.  Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Palliative
14.3.2.Intrinsic Repair Stimulus
14.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Knee
14.4.2.Spine
14.4.3.Ankle
14.4.4.Hip
14.4.5.Others
14.5.  Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Chondroplasty and Microfracture
14.5.2.Autologous Chondrocyte Implantation
14.5.3.Osteochondral Autograft Transplantation
14.5.4.Osteochondral Allograft Transplantation
14.5.5.Juvenile Allograft Fragment
14.5.6.Others
14.6.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.6.1.Ambulatory Care Centres
14.6.2.Hospitals and Clinics
14.6.3.Surgical Centres
14.6.4.Others
14.7.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.7.1.China
14.7.2.India
14.7.3.Australia and New Zealand (ANZ)
14.7.4.Japan
14.7.5.Rest of APAC
15.Middle East and Africa (MEA) Cartilage Repair  And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
15.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.1.1.Fibrocartilage
15.1.2.Hyaline Cartilage
15.1.3.Elastic Cartilage
15.1.4.Others
15.2.  Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.2.1.Cell-based
15.2.2.Non-cell-based
15.3.  Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.3.1.Palliative
15.3.2.Intrinsic Repair Stimulus
15.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.4.1.Knee
15.4.2.Spine
15.4.3.Ankle
15.4.4.Hip
15.4.5.Others
15.5.  Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.5.1.Chondroplasty and Microfracture
15.5.2.Autologous Chondrocyte Implantation
15.5.3.Osteochondral Autograft Transplantation
15.5.4.Osteochondral Allograft Transplantation
15.5.5.Juvenile Allograft Fragment
15.5.6.Others
15.6.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.6.1.Ambulatory Care Centres
15.6.2.Hospitals and Clinics
15.6.3.Surgical Centres
15.6.4.Others
15.7.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15.7.1.GCC Countries
15.7.2.South Africa
15.7.3.Rest of MEA
16.Latin America Cartilage Repair  And Regeneration Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
16.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
16.1.1.Fibrocartilage
16.1.2.Hyaline Cartilage
16.1.3.Elastic Cartilage
16.1.4.Others
16.2.  Treatment Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
16.2.1.Cell-based
16.2.2.Non-cell-based
16.3.  Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
16.3.1.Palliative
16.3.2.Intrinsic Repair Stimulus
16.4.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
16.4.1.Knee
16.4.2.Spine
16.4.3.Ankle
16.4.4.Hip
16.4.5.Others
16.5.  Surgical Procedure Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
16.5.1.Chondroplasty and Microfracture
16.5.2.Autologous Chondrocyte Implantation
16.5.3.Osteochondral Autograft Transplantation
16.5.4.Osteochondral Allograft Transplantation
16.5.5.Juvenile Allograft Fragment
16.5.6.Others
16.6.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
16.6.1.Ambulatory Care Centres
16.6.2.Hospitals and Clinics
16.6.3.Surgical Centres
16.6.4.Others
16.7.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
16.7.1.Brazil
16.7.2.Mexico
16.7.3.Rest of LA
17. Competition Landscape
17.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
17.2.1.AlloSource (U.S.)
17.2.2.Anika Therapeutics, Inc. (U.S.)
17.2.3.Arthrex, Inc. (Germany)
17.2.4.Braun SE (Germany)
17.2.5.BioTissue (U.S.)
17.2.6.CONMED Corporation (U.S.)
17.2.7.LifeNet Health (U.S.)
17.2.8.MEDIPOST (South Korea)
17.2.9.Medtronic (Ireland)
17.2.10.Orthocell Ltd. (Australia)
17.2.11.Osiris Therapeutics, Inc. (U.S.)
17.2.12.RTI Surgical (U.S.)
18. Research Methodology 
19. Appendix and Abbreviations 
  • AlloSource (U.S.)
  • Anika Therapeutics, Inc. (U.S.)
  • Arthrex, Inc. (Germany)
  • Braun SE (Germany)
  • BioTissue (U.S.)
  • CONMED Corporation (U.S.)
  • Geistlich Pharma AG (Switzerland)
  • LifeNet Health (U.S.)
  • MEDIPOST (South Korea)
  • Medtronic (Ireland)
  • Orthocell Ltd. (Australia)
  • Osiris Therapeutics, Inc. (U.S.)
  • RTI Surgical (U.S.)
  • Smith + Nephew (U.K.)
  • Stryker (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • The Future of Biotechnology
  • Vericel Corporation (U.S.)
  • Zimmer Biomet (U.S.)

Adjacent Markets